Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 16/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 7/20 | 0.48 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | HCK | P08631 | 1/20 | 0.48 |
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | JAK3 | P52333 | 1/20 | 0.48 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.48 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31704661 | 0.87 | LCK (0.47) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052554 | 0.85 | LCK (0.41) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31704595 | 0.84 | KDM4E (0.42) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31704600 | 0.84 | LCK (0.51) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31705253 | 0.84 | LCK (0.51) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052540 | 0.84 | MAPK14 (0.53) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052617 | 0.83 | LCK (0.46) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052698 | 0.81 | LCK (0.49) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052577 | 0.79 | MAPK14 (0.44) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052425 | 0.76 | LCK (0.44) | LCKMAPK14MAPK13EGFRFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215187-A1 | THERAPEUTIC COMPOUNDS AND THEIR USE | MY-T BIO LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |